GalenicaGLLNY 80 Net Margin % is 4.34% as of Dec. 2025, which is 3% below its 10-year median of 4.49. GuruFocus rates GLLNY with a GF Score™ of 80/100. The stock has 1 warning sign investors should review. Among 119 Medical Distribution companies, Galenica ranks better than 75.63% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Galenica's Net Income for the
six
months ended in Dec. 2025 was $116.49 Mil. Galenica's Revenue for the
six
months ended in Dec. 2025 was $2,685.73 Mil. Therefore, Galenica's net margin for the quarter that ended in Dec. 2025 was 4.34%.
The historical rank and industry rank for Galenica's Net Margin % or its related term are showing as below:
GLLNY'
s Net Margin % Range Over the Past 10 Years
Min: 2.75 Med: 4.49 Max: 7.62
Current: 4.38
GLLNY's Net Margin % is ranked better than 75.63% of 119
companies
in the Medical Distribution industry
Industry Median: 1.53
vs GLLNY: 4.38
Galenica (OTCPK:GLLNY) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Galenica Net Margin % Related Terms
Galenica Net Margin % Historical Data
* Premium members only.
The historical data trend for Galenica's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Galenica's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's Net Margin % distribution charts can be found below:
* The bar in red indicates where Galenica's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galenica (GLLNY) has a Net Margin % of 4.34% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Galenica and its competitors. This is near median its historical median of 4.49. Over the past decade, Galenica's Net Margin % has ranged from 2.75 to 7.62. According to the industry distribution chart, Galenica ranks #29 out of 119 companies in the Medical Distribution industry, placing it in the top 24.4%.
Is Galenica's Net Margin % too high?
Galenica's current Net Margin % of 4.34% is near median its 10-year median of 4.49. Over the past 10 years, this metric has ranged from a low of 2.75 to a high of 7.62. The Medical Distribution industry median Net Margin % is 1.53. Galenica's value of 4.34% is 183.7% above this industry median. Based on the distribution chart, Galenica ranks #29 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Galenica has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Galenica ranks #29 out of 119 companies for Net Margin %. This places Galenica in the top 24% of its industry — outperforming the majority of peers. The industry median Net Margin % is 1.53. Galenica's value of 4.34% is 183.7% above this benchmark. Historically, Galenica's own Net Margin % has ranged from 2.75 to 7.62 over the past decade. While the company's 10-year median is 4.49 vs. the industry median of 1.53, Galenica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.53, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current Net Margin % of 4.34% is 183.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current Net Margin % is 4.34%, which is near median its own 10-year median of 4.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GLLNY) has a current Net Margin % of 4.34%. The current Net Margin % is 4.34%, which is near median its 10-year median of 4.49 and 183.7% above the Medical Distribution industry median of 1.53. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Galenica (GLLNY), the current Net Margin % is 4.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLLNY has been successfully added to your 